www.crexi.com - The Commercial Real Estate Exchange
Subscribe to Intelligence for full access
Analyze more property details including ownership and financial history. Share advanced property insights with your clients and teams.
Subscribe to Intelligence for full access
Analyze more property details including ownership and financial history. Share advanced property insights with your clients and teams.
33250919
33250925

330 Mount Sinai Dr, Dahlonega, GA 30533 For Sale

NF
AZ AZ0138
JLL Phoenix
AS
IL 475.170243
JLL Chicago | Americas Headquarters
Listed by JLL Phoenix, JLL Chicago | Americas Headquarters
$7,182,000
46 days on market
Updated 30 days ago

Mount Sinai Wellness Center

Details
Property Type Office, Special Purpose
Sub Type Medical Office, Substance Use Disorder Treatment Facility (+1)
Square Footage 54,631
Cap Rate 7.15%
NOI $513,487
Occupancy 100%
Tenancy Single
Lease Type Absolute NNN
Lease Term 15
Lease Expiration 08/31/2033
Remaining Term 7.1
Rent Bumps Yes
Price per SqFt $131
Year Built 1939
Buildings 2
Acreage 43.700
Investment Type Net Lease
Tenant Credit Corporate Guarantee
Lease Commencement 08/29/2018
Ground Lease No

Office | 7.15% CAP | 54,631 SqFt

Marketing description

JLL is pleased to offer the opportunity to acquire Mount Sinai Wellness Center, a 54,631 SF residential drug and alcohol addiction rehabilitation campus situated on 43.7 acres at 330 Mount Sinai Drive in Dahlonega, GA (the "Property" or "Asset"). The Asset is leased to MedMark Treatment Centers of Georgia, Inc. and corporate-guaranteed by BayMark Health Services, Inc., the largest private provider of medication-assisted treatment (MAT) for opioid use disorder in North America, on an absolute NNN lease with no landlord responsibilities, 7.3 years of remaining term, featuring rent escalations of the lesser of 10% or 1.25× the change in CPI every five years and four (4) five-year renewal options.

Mount Sinai Wellness Center operates as a residential SUD treatment facility delivering medically supervised detoxification, dual-diagnosis treatment for co-occurring mental health conditions, and integrated holistic therapies including equine therapy and outdoor programming. The campus serves specialized populations including veterans and is one of 16 residential treatment facilities within BayMark's national continuum of care, which spans 407+ care locations across 36 states and Canada, including 197 Outpatient Treatment Programs, 72 Office-Based Opioid Treatment locations, 26 sober living residences, and contracts with 32 hospitals and 20 correctional facilities.

BayMark Health Services generated $503.2 million in net revenue and $59.6 million in EBITDA in FY2025, reflecting strong rent coverage and operational scale. The substance use disorder treatment industry represents one of the most durable demand stories in U.S. healthcare: the U.S. SUD treatment market is forecast to grow at a 12.3% CAGR through 2033, supported by 48.4M Americans with a substance use disorder, an 80% treatment gap, sustained federal opioid response funding, and regulatory barriers (DEA / SAMHSA certification) that constrain new supply and create defensible operator footprints.

Set within the Blue Ridge foothills, the Property benefits from a purpose-built campus that is exceptionally difficult to replicate — providing the new owner secure, long-term contractual cash flow with zero landlord responsibilities, embedded 10% rent growth, and a national corporate guarantor operating in a recession-resistant healthcare segment.

Investment highlights

  • No landlord expenses
  • 7.3 Years lease term remaining
  • Lesser of 10.00% or 1.25x CPI rental increases every 5 years
  • Corporate guaranty from the largest private MAT provider for opioid use disorder in North America
  • $503M Guarantor annual revenue
  • Purpose-built, mission-critical residential SUD treatment campus on 43.7 acres — irreplaceable footprint
  • 12.3% CAGR Projected U.S. substance abuse treatment market growth (2025–2033)
  • Located 55 miles north of downtown Atlanta

Listing Contacts

NF
AZ AZ0138
JLL Phoenix
AS
IL 475.170243
JLL Chicago | Americas Headquarters
Listed by JLL Phoenix, JLL Chicago | Americas Headquarters

Valuation Calculator

Login or Sign up to see Valuation Metrics
Sign up for Crexi to see valuation metrics for this property
$
$
%
Loan Amount
$0.00
Annual Debt Service
$--
$--
Annual Cash Flow
$513,487.00
$42,790.58/mo

Valuation Metrics

0
DSCR
7.15%
Cap Rate
7.15%
ROI

Broker Selected Comps View More Comps

Property History

Intelligence Badge

Similar Properties

View All
*All information is deemed reliable but not guaranteed. Buyer to verify all information.
Is there information that looks off?
For assistance, reach out to our support team at [email protected] or call 888.273.0423 . For press inquiries, contact [email protected]
Equal Housing Opportunity
5510 Lincoln Blvd #400, Los Angeles, CA 90094Commercial Real Estate Exchange, Inc.Crexi Technologies, LLCCXTechnology, LLC
© 2026 Commercial Real Estate Exchange, Inc. All Rights Reserved. DRE #02086591